These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9315539)

  • 1. Enalapril does not enhance exercise capacity in patients after Fontan procedure.
    Kouatli AA; Garcia JA; Zellers TM; Weinstein EM; Mahony L
    Circulation; 1997 Sep; 96(5):1507-12. PubMed ID: 9315539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of an angiotensin-converting inhibitor (enalapril) on patients with mild cardiac failure--evaluating cardiac function based on the relationship between daily walking pace and heart rate.
    Inooka E; Umeda S; Kutsuwa Y; Takahashi T; Sagawa K; Takahashi T; Inooka H
    Clin Cardiol; 1998 Dec; 21(12):893-8. PubMed ID: 9853181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.
    Ormesher L; Higson S; Luckie M; Roberts SA; Glossop H; Trafford A; Cottrell E; Johnstone ED; Myers JE
    Hypertension; 2020 Dec; 76(6):1828-1837. PubMed ID: 33012200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leg-focused high-weight resistance training improves ventricular stroke volume, exercise capacity and strength in young patients with a Fontan circulation.
    Scheffers LE; Helbing WA; Pereira T; Utens EMWJ; Dulfer K; Hirsch A; Koopman LP; van den Berg LE
    Eur J Prev Cardiol; 2024 Mar; 31(4):389-399. PubMed ID: 37668334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation.
    Edelson JB; Zak V; Goldberg D; Fleming G; Mackie AS; Patel JK; Files M; Downing T; Richmond M; Acheampong B; Cartoski M; Detterich J; McCrindle B; McHugh K; Hansen JE; Wagner J; Maria MD; Weingarten A; Nowlen T; Yoon JK; Kim GB; Williams R; Whitehill R; Kirkpatrick E; Yin S; Ermis P; Lubert AM; Stylianou M; Freemon D; Hu C; Garuba OD; Frommelt P; Goldstein BH; Paridon S; Garg R;
    Am J Cardiol; 2024 Jan; 210():183-187. PubMed ID: 37918818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise capacity and muscle strength in patients who have undergone the Fontan procedure: a retrospective follow-up study.
    Tekerlek H; Sağlam M; Selçuk SN; Aykan HH; Vardar Yağlı N; Çalık Kütükcü E; İnal İnce D; Karagöz T
    Turk J Pediatr; 2024 May; 66(2):226-236. PubMed ID: 38814303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
    Selamet Tierney ES; Palaniappan L; Leonard M; Long J; Myers J; Dávila T; Lui MC; Kogan F; Olson I; Punn R; Desai M; Schneider LM; Wang CH; Cooke JP; Bernstein D
    Am Heart J; 2023 May; 259():68-78. PubMed ID: 36796574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular remodelling in response to exercise training in patients after the Fontan procedure: a pilot study.
    Bano M; Hussain T; Samels MR; Butts RJ; Kirk R; Levine BD
    Cardiol Young; 2024 Mar; 34(3):604-613. PubMed ID: 37664999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise Capacity and Training Programs in Paediatric Fontan Patients: A Systematic Review.
    Herrmann JE; Selamet Tierney ES
    CJC Pediatr Congenit Heart Dis; 2022 Jun; 1(3):108-118. PubMed ID: 37970491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise prescription for patients with a Fontan circulation: current evidence and future directions.
    Takken T; Hulzebos HJ; Blank AC; Tacken MH; Helders PJ; Strengers JL
    Neth Heart J; 2007; 15(4):142-7. PubMed ID: 17612674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices.
    Vaikunth S; Sundaravel S; Saef J; Ortega-Legaspi J
    Curr Heart Fail Rep; 2023 Oct; 20(5):401-416. PubMed ID: 37582901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Drugs in ACHD Cardiovascular Medicine.
    Ladouceur M; Valdeolmillos E; Karsenty C; Hascoet S; Moceri P; Le Gloan L
    J Cardiovasc Dev Dis; 2023 Apr; 10(5):. PubMed ID: 37233157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of circulatory failure after Fontan surgery.
    Kamsheh AM; O'Connor MJ; Rossano JW
    Front Pediatr; 2022; 10():1020984. PubMed ID: 36425396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of aggressive arterial and venous dilation therapy in addition to pulmonary dilation therapy (super-Fontan strategy) improves Fontan circulation both at rest and during treadmill exercise.
    Ishikawa S; Matsumura S; Yana A; Kurishima C; Iwamoto Y; Ishido H; Masutani S; Nakagawa R; Senzaki H
    JTCVS Open; 2022 Sep; 11():388-397. PubMed ID: 36172449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercising with a Single Ventricle: Limitations and Therapies.
    Haley JE; Davis C
    J Cardiovasc Dev Dis; 2022 May; 9(6):. PubMed ID: 35735796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology Management in Improving Exercise Capacity of Patients with Fontan Circulation: A Systematic Review and Meta-analysis.
    Mendel B; Christianto ; Setiawan M; Siagian SN; Prakoso R
    Curr Cardiol Rev; 2022; 18(5):34-49. PubMed ID: 35379155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.
    Tran DL; Gibson H; Maiorana AJ; Verrall CE; Baker DW; Clode M; Lubans DR; Zannino D; Bullock A; Ferrie S; Briody J; Simm P; Wijesekera V; D'Almeida M; Gosbell SE; Davis GM; Weintraub R; Keech AC; Puranik R; Ugander M; Justo R; Zentner D; Majumdar A; Grigg L; Coombes JS; d'Udekem Y; Morris NR; Ayer J; Celermajer DS; Cordina R
    Front Pediatr; 2021; 9():799125. PubMed ID: 35071139
    [No Abstract]   [Full Text] [Related]  

  • 18. Current Treatment Options for the Failing Fontan Circulation.
    Driesen BW; Voskuil M; Grotenhuis HB
    Curr Cardiol Rev; 2022; 18(4):e060122200067. PubMed ID: 34994331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.
    Garcia AM; Beatty JT; Nakano SJ
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H947-H965. PubMed ID: 32108525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Heart Failure in Adult Congenital Heart Disease.
    Sabanayagam A; Cavus O; Williams J; Bradley E
    Heart Fail Clin; 2018 Oct; 14(4):569-577. PubMed ID: 30266365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.